ARCHIVES

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 6 | June 30, 2006

Download PDF Visit The Full Archive

Related Articles

Advances In Cancer Control Meeting Is Set For March 22

February 3, 1989

Senate Votes To Kill A 10% Cut For NIH; Less Severe Budget Cuts Still Possible

May 26, 1995

Conversation with The Cancer Letter: Is Republican Control Better Than Two-Party Stalemate?

December 19, 2014

HHS To Determine Feasibility Of CHOP Evaluation

July 24, 1981

Afinitor Extends PFS In Women With EGFR-2 Positive Disease

June 28, 2013

Hayloc, Krebs Lead Oncology Nurses

May 16, 1997